Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey

The present paper aims to provide experts' consensus on diagnosis and management of cow's milk protein allergy (CMPA) among infants and children in Turkey, based on review of available evidence-based guidelines, publications and experts' clinical experience. The experts agreed...

Full description

Saved in:
Bibliographic Details
Main Authors: Aydan Kansu, Aysel Yüce, Buket Dalgıç, Bülent Enis Şekerel, Fügen Çullu-Çokuğraş, Haluk Çokuğraş
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2016-02-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/1063
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236821405958144
author Aydan Kansu
Aysel Yüce
Buket Dalgıç
Bülent Enis Şekerel
Fügen Çullu-Çokuğraş
Haluk Çokuğraş
author_facet Aydan Kansu
Aysel Yüce
Buket Dalgıç
Bülent Enis Şekerel
Fügen Çullu-Çokuğraş
Haluk Çokuğraş
author_sort Aydan Kansu
collection DOAJ
description The present paper aims to provide experts' consensus on diagnosis and management of cow's milk protein allergy (CMPA) among infants and children in Turkey, based on review of available evidence-based guidelines, publications and experts' clinical experience. The experts agreed that CMPA diagnosis should be based on symptomatic evaluation and diagnostic elimination diet as followed by implementation of an open challenge test after disappearance of symptoms and confirmation of CMPA diagnosis in re-appearance of symptoms. For breastfed infants, differential diagnosis involves withdrawal of cow's milk-containing products from the mother's diet, while calcium supplements and appropriate dietary advice are given to mothers to prevent nutritional deficiency. For infants not breastfed exclusively, cow's milk-based formula and any complementary food containing cow's milk protein (CMP) should be avoided. The first line treatment should be extensively hydrolyzed formula (eHF) with use of amino acid-based formula (AAF) in severe cases such as anaphylaxis, enteropathy, eosinophilic esophagitis and food protein induced enterocolitis along with cases of multiple system involvement, multiple food allergies and intolerance to eHF. Introduction of supplementary foods should not be delayed in CMPA, while should be made one by one in small amounts and only after the infant is at least 17 weeks of age. Infants who are at-risk can be identified by family history of atopic disease. Exclusive breastfeeding for 4-6 months (17-27 weeks) is recommended as the best method of infant allergy prevention. There is no evidence that modifying the mother's diet during pregnancy and/or breast-feeding and delaying solid or even potentially allergic foods beyond 4-6 months in infants may be protective against allergy among at-risk infants. When exclusive breastfeeding is not possible, at-risk infants should get a partially or extensively hydrolyzed formula (pHF or eHF) to prevent allergy until risk evaluation by a health professional. In conclusion, the present consensus statement provides recommendations regarding diagnosis, prevention and management of CMPA in infants and children in Turkey, and thus expected to guide physicians to optimize their approach to CMPA and decrease burden of the disease on infants and their caregivers.
format Article
id doaj-art-e74f11c6eb5b40fb8b57dd1b76807314
institution OA Journals
issn 0041-4301
2791-6421
language English
publishDate 2016-02-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-e74f11c6eb5b40fb8b57dd1b768073142025-08-20T02:01:53ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212016-02-0158110.24953/turkjped.2016.01.001Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in TurkeyAydan Kansu0Aysel Yüce1Buket Dalgıç2Bülent Enis Şekerel3Fügen Çullu-Çokuğraş4Haluk Çokuğraş5Division of Pediatric Gastroenterology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Gastroenterology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Gastroenterology, Department of Pediatrics, Gazi University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Allergy and Asthma, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Gastroenterology, Department of Pediatrics, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.Division of Pediatric Allergy, Department of Pediatrics, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey. The present paper aims to provide experts' consensus on diagnosis and management of cow's milk protein allergy (CMPA) among infants and children in Turkey, based on review of available evidence-based guidelines, publications and experts' clinical experience. The experts agreed that CMPA diagnosis should be based on symptomatic evaluation and diagnostic elimination diet as followed by implementation of an open challenge test after disappearance of symptoms and confirmation of CMPA diagnosis in re-appearance of symptoms. For breastfed infants, differential diagnosis involves withdrawal of cow's milk-containing products from the mother's diet, while calcium supplements and appropriate dietary advice are given to mothers to prevent nutritional deficiency. For infants not breastfed exclusively, cow's milk-based formula and any complementary food containing cow's milk protein (CMP) should be avoided. The first line treatment should be extensively hydrolyzed formula (eHF) with use of amino acid-based formula (AAF) in severe cases such as anaphylaxis, enteropathy, eosinophilic esophagitis and food protein induced enterocolitis along with cases of multiple system involvement, multiple food allergies and intolerance to eHF. Introduction of supplementary foods should not be delayed in CMPA, while should be made one by one in small amounts and only after the infant is at least 17 weeks of age. Infants who are at-risk can be identified by family history of atopic disease. Exclusive breastfeeding for 4-6 months (17-27 weeks) is recommended as the best method of infant allergy prevention. There is no evidence that modifying the mother's diet during pregnancy and/or breast-feeding and delaying solid or even potentially allergic foods beyond 4-6 months in infants may be protective against allergy among at-risk infants. When exclusive breastfeeding is not possible, at-risk infants should get a partially or extensively hydrolyzed formula (pHF or eHF) to prevent allergy until risk evaluation by a health professional. In conclusion, the present consensus statement provides recommendations regarding diagnosis, prevention and management of CMPA in infants and children in Turkey, and thus expected to guide physicians to optimize their approach to CMPA and decrease burden of the disease on infants and their caregivers. https://turkjpediatr.org/article/view/1063Turkeyclinical practicecow’s milk protein allergydiagnosisguidelinesprevention
spellingShingle Aydan Kansu
Aysel Yüce
Buket Dalgıç
Bülent Enis Şekerel
Fügen Çullu-Çokuğraş
Haluk Çokuğraş
Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey
The Turkish Journal of Pediatrics
Turkey
clinical practice
cow’s milk protein allergy
diagnosis
guidelines
prevention
title Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey
title_full Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey
title_fullStr Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey
title_full_unstemmed Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey
title_short Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey
title_sort consensus statement on diagnosis treatment and follow up of cow s milk protein allergy among infants and children in turkey
topic Turkey
clinical practice
cow’s milk protein allergy
diagnosis
guidelines
prevention
url https://turkjpediatr.org/article/view/1063
work_keys_str_mv AT aydankansu consensusstatementondiagnosistreatmentandfollowupofcowsmilkproteinallergyamonginfantsandchildreninturkey
AT ayselyuce consensusstatementondiagnosistreatmentandfollowupofcowsmilkproteinallergyamonginfantsandchildreninturkey
AT buketdalgıc consensusstatementondiagnosistreatmentandfollowupofcowsmilkproteinallergyamonginfantsandchildreninturkey
AT bulentenissekerel consensusstatementondiagnosistreatmentandfollowupofcowsmilkproteinallergyamonginfantsandchildreninturkey
AT fugencullucokugras consensusstatementondiagnosistreatmentandfollowupofcowsmilkproteinallergyamonginfantsandchildreninturkey
AT halukcokugras consensusstatementondiagnosistreatmentandfollowupofcowsmilkproteinallergyamonginfantsandchildreninturkey